PMID- 32286011 OWN - NLM STAT- MEDLINE DCOM- 20210512 LR - 20210512 IS - 1467-789X (Electronic) IS - 1467-7881 (Print) IS - 1467-7881 (Linking) VI - 21 IP - 8 DP - 2020 Aug TI - Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials. PG - e13030 LID - 10.1111/obr.13030 [doi] LID - e13030 AB - A network meta-analysis of randomized controlled trials (RCTs) was performed to determine the hierarchies of different bariatric surgeries in patients with obesity and type 2 diabetes mellitus (T2DM), in terms of diabetes remission and cardiometabolic outcomes. Seventeen RCTs and six bariatric surgeries, including single anastomosis (mini) gastric bypass (mini-GBP), biliopancreatic diversion without duodenal switch (BPD), laparoscopic-adjustable gastric banding (LAGB), laparoscopic sleeve gastrectomy (LSG), Roux-en-Y gastric bypass (RYGBP), greater curvature plication (GCP) and nonsurgical treatments (NST) were included. Mini-GBP, BPD, LSG, RYGBP and LAGB (from best to worst), as compared with NST, were all significantly associated with the remission of T2DM. For the follow-up period > 3 years, BPD, mini-GBP, RYGBP and LSG (from best to worst) were significantly superior to NST in achieving the remission of T2DM. For secondary outcomes, the overall ranking for bariatric surgeries was RYGBP > BPD > LSG > LAGB after comprehensively weighting glucose, weight, systolic and diastolic pressure, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). Mini-GBP has the greatest probability of achieving diabetes remission in adults with obesity and T2DM, yet BPD was the most effective in long-term diabetes remission. RYGBP appears to be the most favourable alternative treatment to manage patients with cardiometabolic conditions. CI - (c) 2020 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation. FAU - Ding, Li AU - Ding L AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Fan, Yuxin AU - Fan Y AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Li, Hui AU - Li H AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Zhang, Yalan AU - Zhang Y AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Qi, Dongwang AU - Qi D AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Tang, Shaofang AU - Tang S AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Cui, Jingqiu AU - Cui J AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - He, Qing AU - He Q AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. FAU - Zhuo, Chuanjun AU - Zhuo C AUID- ORCID: 0000-0002-3793-550X AD - Department of School of Mental Health, Jining Medical University, Jining, China. FAU - Liu, Ming AU - Liu M AD - Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, China. LA - eng GR - 17JCZDJC35700/Tianjin Municipal Science and Technology Commission/International GR - 17ZXMFSY00150/Tianjin Municipal Science and Technology Commission/International GR - 19JCQNJC11800/Tianjin Municipal Science and Technology Commission/International GR - 81620108004/National Natural Science Foundation of China/International GR - 81830025/National Natural Science Foundation of China/International GR - 81871052/National Natural Science Foundation of China/International GR - 2019YFA0802502/National Key R&D Program of China/International PT - Comparative Study PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20200414 PL - England TA - Obes Rev JT - Obesity reviews : an official journal of the International Association for the Study of Obesity JID - 100897395 SB - IM MH - Bariatric Surgery/*methods MH - Diabetes Mellitus, Type 2/*complications/*therapy MH - Female MH - Humans MH - Male MH - Middle Aged MH - Network Meta-Analysis MH - Obesity/*complications/*surgery MH - Randomized Controlled Trials as Topic MH - Treatment Outcome PMC - PMC7379237 OTO - NOTNLM OT - bariatric surgeries OT - cardiometabolic outcome OT - diabetes remission OT - network meta-analysis COIS- The authors confirm that there are no conflicts of interest. EDAT- 2020/04/15 06:00 MHDA- 2021/05/13 06:00 PMCR- 2020/07/24 CRDT- 2020/04/15 06:00 PHST- 2019/12/10 00:00 [received] PHST- 2020/03/26 00:00 [revised] PHST- 2020/03/26 00:00 [accepted] PHST- 2020/04/15 06:00 [pubmed] PHST- 2021/05/13 06:00 [medline] PHST- 2020/04/15 06:00 [entrez] PHST- 2020/07/24 00:00 [pmc-release] AID - OBR13030 [pii] AID - 10.1111/obr.13030 [doi] PST - ppublish SO - Obes Rev. 2020 Aug;21(8):e13030. doi: 10.1111/obr.13030. Epub 2020 Apr 14.